(2014) showed that in a targeted knock-down screen of inositide-metabolising enzymes, PI5P4Kα emerged with a strong role in acute myeloid leukaemia (AML) cell proliferation and survival. The gene discussed is PIP4K2A; the disease is acute myeloid leukemia.